Benitec Biopharma (BNTC) Accumulated Depreciation & Amortization (2019 - 2025)
Historic Accumulated Depreciation & Amortization for Benitec Biopharma (BNTC) over the last 7 years, with Q1 2025 value amounting to $52000.0.
- Benitec Biopharma's Accumulated Depreciation & Amortization rose 10800.0% to $52000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $52000.0, marking a year-over-year increase of 10800.0%. This contributed to the annual value of $87000.0 for FY2024, which is 3602.94% down from last year.
- According to the latest figures from Q1 2025, Benitec Biopharma's Accumulated Depreciation & Amortization is $52000.0, which was up 10800.0% from $39000.0 recorded in Q4 2024.
- In the past 5 years, Benitec Biopharma's Accumulated Depreciation & Amortization registered a high of $231000.0 during Q2 2021, and its lowest value of $17000.0 during Q4 2023.
- Over the past 5 years, Benitec Biopharma's median Accumulated Depreciation & Amortization value was $52000.0 (recorded in 2021), while the average stood at $73705.9.
- As far as peak fluctuations go, Benitec Biopharma's Accumulated Depreciation & Amortization crashed by 6983.24% in 2022, and later skyrocketed by 12941.18% in 2024.
- Quarter analysis of 5 years shows Benitec Biopharma's Accumulated Depreciation & Amortization stood at $55000.0 in 2021, then dropped by 25.45% to $41000.0 in 2022, then tumbled by 58.54% to $17000.0 in 2023, then skyrocketed by 129.41% to $39000.0 in 2024, then soared by 33.33% to $52000.0 in 2025.
- Its Accumulated Depreciation & Amortization was $52000.0 in Q1 2025, compared to $39000.0 in Q4 2024 and $25000.0 in Q3 2024.